- Home
- APLT vs HFBL Comparison
APLT vs HFBL Comparison
Compare APLT & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- HFBL
- Stock Information
- Founded
- APLT 2016
- HFBL 1924
- Country
- APLT United States
- HFBL United States
- Employees
- APLT N/A
- HFBL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- HFBL Savings Institutions
- Sector
- APLT Health Care
- HFBL Finance
- Exchange
- APLT Nasdaq
- HFBL Nasdaq
- Market Cap
- APLT 44.0M
- HFBL 40.8M
- IPO Year
- APLT 2019
- HFBL N/A
- Fundamental
- Price
- APLT $0.39
- HFBL $13.77
- Analyst Decision
- APLT Buy
- HFBL
- Analyst Count
- APLT 7
- HFBL 0
- Target Price
- APLT $6.10
- HFBL N/A
- AVG Volume (30 Days)
- APLT 2.4M
- HFBL 6.5K
- Earning Date
- APLT 08-06-2025
- HFBL 07-25-2025
- Dividend Yield
- APLT N/A
- HFBL 3.78%
- EPS Growth
- APLT N/A
- HFBL N/A
- EPS
- APLT N/A
- HFBL 1.09
- Revenue
- APLT $265,000.00
- HFBL $20,019,000.00
- Revenue This Year
- APLT $1,768.13
- HFBL N/A
- Revenue Next Year
- APLT $292.85
- HFBL N/A
- P/E Ratio
- APLT N/A
- HFBL $12.60
- Revenue Growth
- APLT N/A
- HFBL N/A
- 52 Week Low
- APLT $0.30
- HFBL $11.06
- 52 Week High
- APLT $10.62
- HFBL $14.25
- Technical
- Relative Strength Index (RSI)
- APLT 51.68
- HFBL 57.33
- Support Level
- APLT $0.32
- HFBL $13.22
- Resistance Level
- APLT $0.36
- HFBL $13.65
- Average True Range (ATR)
- APLT 0.03
- HFBL 0.20
- MACD
- APLT 0.00
- HFBL 0.06
- Stochastic Oscillator
- APLT 73.78
- HFBL 86.31
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.